Developing an intervention for cancer patients prescribed oral chemotherapy: a generic patient diary
Corresponding Author
C. OAKLEY msc, rn, chemotherapy nurse consultant
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, Level 4 Bermondsey Wing, London
Catherine Oakley, Chemotherapy Nurse Consultant, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, Level 4 Bermondsey Wing, London SE1 9RT, UK (e-mail: [email protected]). Search for more papers by this authorJ. JOHNSON rn, neuro-oncology clinical nurse specialist
St George's NHS Healthcare Trust, London
Search for more papers by this authorE. REAM phd, rn, professor of supportive cancer care
Florence Nightingale School of Nursing & Midwifery, King's College London, London, UK
Search for more papers by this authorCorresponding Author
C. OAKLEY msc, rn, chemotherapy nurse consultant
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, Level 4 Bermondsey Wing, London
Catherine Oakley, Chemotherapy Nurse Consultant, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, Level 4 Bermondsey Wing, London SE1 9RT, UK (e-mail: [email protected]). Search for more papers by this authorJ. JOHNSON rn, neuro-oncology clinical nurse specialist
St George's NHS Healthcare Trust, London
Search for more papers by this authorE. REAM phd, rn, professor of supportive cancer care
Florence Nightingale School of Nursing & Midwifery, King's College London, London, UK
Search for more papers by this authorConflict of interest statement: Catherine Oakley has, during the last year, served on an advisory board, and received consulting and speaker honoraria from Pfizer.
Abstract
OAKLEY C., JOHNSON J. & REAM E. (2010) European Journal of Cancer Care19, 21–28Developing an intervention for cancer patients prescribed oral chemotherapy: a generic patient diary
Oral chemotherapy is playing a prominent role in the development of new cancer treatments. Research suggests that although oral chemotherapy is viewed as easier to manage and more cost effective than intravenous alternatives, patients do not always find it easier to cope with. The research reported in this paper comprised three phases, a review of the literature, an ethnographic study and a feasibility study. The ethnographic study focused on the experience of patients undergoing oral chemotherapy and demonstrated that patients, carers and family members found managing the treatment challenging. Many highlighted that a patient held diary would assist them with maintaining adherence, recording doses taken and identifying side effects. The authors worked closely with stakeholders, including patients, to corroborate what key elements should be included in such a diary. A generic diary was then introduced into clinical practice and its acceptability explored through a feasibility study. The results of this study showed that patients found the diary effective and useful. Trends emerged showing an association between effective symptom management and increased self-efficacy. The research also highlighted that the diary should be supported by a model of care to enhance education and reiterate information. Use of the diary, and a model of care to support it, could enable concerns highlighted about patient safety and the risks associated with oral chemotherapy to be addressed.
REFERENCES
-
Bloomfield J. &
Plant H. (2006) Oral anti-cancer therapies.
European Journal of Cancer Care
15, 404–418.
10.1111/j.1365-2354.2006.00713.x Google Scholar
- Chau I., Legge S. & Fumoleau P. (2004) The vital role of education and information in patients receiving capecitabine (Xeloda). European Journal of Oncology Nursing 8, S41–S53.
- Cresswell J. (2003) Research Design: Qualitative, Quantitative and Mixed Methods Approaches, 2nd edn. Sage Publications, Inc, London, UK.
- Dauz Williams P., Piamjariyakul U., Ducey K., Badura J., Boltz K.D., Olberding K., Wingate A. & Williams A. (2006) Cancer treatment, symptom monitoring, and self care in adults. Cancer Nursing 29, 347–355.
- Deery P. & Faithfull S. (2003) Developing a patient pathway to deliver a new oral chemotherapy. Professional Nurse 19, 102–106.
- Dixon-Woods M. (2003) What can ethnography do for quality and safety in healthcare? Quality and Safety in Healthcare 12, 326–327.
- Fenlon D. & Foster C. (2009) Self Management Support: A Review of the Evidence. Macmillan Research Unit, University of Southampton, Southampton, UK.
- Gerbrecht B. & Kangas T. (2004) Implications of capecitabine (Xeloda) for cancer nursing practice. European Journal of Oncology Nursing 8, S63–S71.
- Green J. & Thorogood N. (2004) Qualitative Methods for Health Research. Sage Publications, London, UK.
- Hammersley M. & Atkinson P. (1995) Ethnography: Principles in Practice. Tavistoke, London, UK.
-
Hartigan K. (2002) Patient education: The cornerstone of successful oral chemotherapy treatment.
Clinical Journal of Oncology Nursing
supplement, 7, 21–24.
10.1188/03.CJON.S6.21-24 Google Scholar
- Kav S. & Bostanci H. (2006) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey. Supportive Cancer Care 14, 1252–1257.
-
Lebovits A.H.,
Strainn J.J. &
Schleifer S.J. (1990) Patient non-compliance with self-administered chemotherapy.
Cancer
65, 17–22.
10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Lee C.R., Nicholson P.W., Souhami R.L., Slevin M.L., Hall M.R. & Deshmukh A.A. (1993) Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer. British Journal of Cancer 67, 630–634.
- Lee C.R., Nicholson P.W., Lederman J.A. & Rustin G.J.S. (1996) Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer. Europeon Journal of Gynaecological Oncology 17, 99–103.
- Lev E., Paul D. & Owen S. (1999) Age, self efficacy, and change in patients' adjustment to cancer. Cancer Practice 7, 170–176.
- Levanthal H., Nerenz D., Leventhal E., Love R. & Bendena L. (1991) The behavioural dynamics of clinical trials. Preventative Medicine 20, 132–146.
- Levine A.M., Richardson J.L., Marks G., Chan K., Graham J., Selser J.N., Kishbaugh C., Shelton D.R. & Anderson Johnson C. (1987) Compliance with oral drug therapy in patients with hematologic malignancy. Journal of Clinical Oncology 5, 1469–1476.
- Liu G., Franssen E., Fitch M.I. & Warner E. (1997) Patient preferences for oral versus IV palliative chemotherapy. Journal of Clinical Oncology 15, 110–115.
- Lorig K., Sobel D., Stewart A., Brown B., Bandura A., Ritter P., Gonzalez V., Laurent D. & Holman H. (1999) Evidence suggested that a chronic disease self management program can improve health status while reducing hospitalization. Medical Care 37, 5–14.
- McCaughan E.M. & Thompson K.A. (2000) Information needs of cancer patients receiving chemotherapy at a day-case unit in Northern Ireland. Journal of Clinical Nursing 9, 851–858.
-
McKendrick J.J.,
Cassidy J.,
Chakrapee-Sirisuk S.,
Fountzilas G.,
Iveson T.,
Jelic S.,
Karnicka-Mlodkowska H.,
Ostojic R.,
Scheithauer W. &
Twelves C. (2004) Capecitabine (X) is resource saving compared with IV. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT).
Journal of Clinical Oncology
ASCO Annual Meeting Proceedings (Post-Meeting Edition), 22 (Suppl.
14) (July 15 Supplement), 2004: 3578.
10.1200/jco.2004.22.14_suppl.3578 Google Scholar
-
Macleod A.,
Branch A.,
Cassidy J.,
McDonald A. &
Mohammed N. (2007) A nurse-pharmacy-led capecitabine clinic for colorectal cancer: Results of a prospective audit and retrospective survey of patient experiences.
European Journal of Oncology Nursing
11, 247–254.
10.1016/j.ejon.2006.10.001 Google Scholar
- Merluzzi T.V. & Sanchez M.A. (1997) Assessment of self efficacy and coping with cancer: development and validation of the cancer behaviour inventory. Health Psychology 16, 163–170.
- Molassiotis A., Brearley S., Saunders M., Craven O., Wardley A., Farrell C., Swindell R., Todd C. & Luker K. (2009) Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. Journal of Clinical Oncology 27, 6191–6198.
- Medical Research Council (MRC) (2008) Developing and Evaluating Complex Interventions: New Guidance. Available at: http://www.mrc.ac.uk/complexinterventionsguidance/.
- National Chemotherapy Advisory Group (2009) Chemotherapy Services in England: Ensuring Quality and Safety. DH, London, UK.
- National Patient Safety Agency (2008) Risks of Incorrect Dosing of Oral Anti-Cancer Medicines (NPSA/2008/RRR001). DH, London, UK.
- NICE Technology Appraisal, No. 61. (2003). Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer (May 2003).
- Partridge A.H., Avon J., Wang P.S. & Winer E.P. (2002) Adherence to therapy with oral antineoplastic agents. Journal of the National Cancer Institute 94, 652–661.
- Partridge A.H., Wang P.S., Winer E.P. & Avorn J. (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology 21, 602–606.
- Partridge A.H., LaFountain A., Mayer E., Taylor S.B., Winer E. & Asnis-Alibozek A.A. (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. Journal of Clinical Oncology 26940, 556–562.
- Portenoy R.K., Thaler H.T., Kornblith A.B., Lepore J.M., Friedlander-Klar H., Kiyasu E., Sobel K., Coyle N., Kemeny N. & Norton L. (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer 30A, 1326–1336.
- Redfern J., Rudd A.D., Wolfe C.D. & McKevitt C. (2008) Stop Stroke; Development of an innovative intervention to improve risk factor management after stroke. Patient Education and Counselling 72, 201–209.
- Ritchie J. & Lewis J. (2006) Qualitative Research Practice: A Guide for Social Science Students and Researchers, 5th edn. SAGE Publications Ltd, London, UK.
- Ritchie J. & Spencer L. (2004) Qualitative data analysis for applied policy research. In: Analysing Qualitative Data (ed. A. Bryman & R. Burgess), pp. 173–194. Routledge, West Sussex, UK.
- Savage J. (2000) Ethnography and health care. British Medical Journal 321, 1400–1402.
- Skalla K.A., Bakitas M., Furstenberg C., Ahles T. & Henderson J.V. (2004) Patients need for information about cancer therapy. Oncology Nursing Forum 31, 313–319.
- Twelves C., Boyer M., Findlay M., Cassidy J., Weitzel C., Barker C., Osterwalder B., Jamieson C. & Hieke K. on behalf of the Xeloda colorectal cancer study group (2001) Capectiabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Journal of Cancer 37, 597–604.
- Twelves C., Gollins S., Grieve R. & Samuel L. (2006) A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Annals of Oncology 17, 239–245.
- Waterhouse D.M., Calzone K.A., Mele C. & Brenner D.E. (1993) Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology 11, 1189–1197.
- Weingart S.N., Flug J., Brouillard D., Morway L., Partridge A., Bartel S., Shulman L.N. & Connor M. (2007) Oral chemotherapy safety practices at US cancer centres: questionnaire survey. British Medical Journal BMJ, doi:10.1136/BMJ.39069.489757.55; published 12 January 2007.